Cyclin-dependent kinase 1 (CDK1) mRNA (CDK1 mRNA)

Cyclin-dependent kinase 1 (CDK1) mRNA is the messenger RNA transcript that encodes the CDK1 protein, a fundamental serine/threonine kinase essential for the eukaryotic cell cycle (NCBI Gene ID: 983). As the primary driver of the G2 to M phase transition, CDK1 forms a catalytic complex with regulatory B-type cyclins to trigger mitosis through the phosphorylation of various structural and regulatory proteins (UniProt P06493). In many oncogenic contexts, CDK1 mRNA is significantly overexpressed, facilitating rapid and unchecked cellular proliferation, which makes it an attractive target for therapeutic intervention (PubMed: 21832171). While traditional pharmacological approaches focus on small-molecule inhibition of the CDK1 protein, targeting the mRNA transcript via RNA interference (RNAi) or antisense oligonucleotides (ASOs) offers a strategy to selectively deplete the protein pool and circumvent the lack of specificity often seen with pan-CDK inhibitors. Experimental studies have demonstrated that silencing CDK1 mRNA can induce cell cycle arrest and apoptosis in various cancer cell lines, although clinical translation remains challenging due to the protein's critical role in normal proliferating tissues (PubMed: 30217988). Monitoring CDK1 mRNA levels also serves as a valuable prognostic biomarker in several malignancies, reflecting the proliferative index of the tumor (Wikipedia: Cyclin-dependent kinase 1).

Other names

CDC2 mRNACell division control protein 2 homolog mRNAP34 protein kinase mRNACDKN1 mRNA

RNA interference (RNAi) or antisense-mediated degradation of mRNA leading to reduced protein expression.